State NV
Clinical Trials in Nevada
Nevada is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Nevada and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 91 actively recruiting studies with Nevada sites out of 91 registered in total. The busiest research areas in Nevada are Breast Cancer, Ovarian Neoplasms, Metastatic Breast Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), AstraZeneca, Eli Lilly and Company. By stage, Nevada trials break down as Phase 1 (7), Phase 2 (26), Phase 3 (42), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Nevada
Frequently Asked Questions — Clinical Trials in Nevada
How many clinical trials are currently recruiting in Nevada?
ClinicalMetric currently tracks 91 actively recruiting clinical trials with at least one location in Nevada. The total number of registered studies—including active but not currently enrolling trials—is 91. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nevada?
Nevada hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Neoplasms, Metastatic Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nevada serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nevada?
To join a clinical trial in Nevada, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nevada maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Nevada
NCT06982521 Phase 3
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatme...
Condition
PIK3CA Mutation
Enrollment
540 pts
Location
United States, Argentina, Australia
Sponsor
Relay Therapeutics, Inc.
NCT04853251 Phase 4
Recruiting
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
188 pts
Location
United States
Sponsor
Genentech, Inc.
NCT07552077 Phase 2
Recruiting
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-0...
Condition
Angiokeratomas
Enrollment
15 pts
Location
United States
Sponsor
Palvella Therapeutics, Inc.
NCT07089875 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Condition
Gout
Enrollment
500 pts
Location
United States, Poland, Spain
Sponsor
Crystalys Therapeutics
NCT07142356 Phase 2
Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Condition
Uncontrolled Hypertension
Enrollment
280 pts
Location
United States
Sponsor
Retension Pharmaceuticals. Inc
NCT06779773 N/A
Recruiting
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice ...
Condition
Geographic Atrophy
Enrollment
500 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT07481630 Phase 3
Recruiting
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People W...
Condition
Obesity
Enrollment
400 pts
Location
United States, Australia, Bulgaria
Sponsor
Novo Nordisk A/S
NCT06577987 Phase 1
Recruiting
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignanc...
Condition
Advanced Solid Tumor
Enrollment
220 pts
Location
United States
Sponsor
Circle Pharma
NCT04389632 Phase 1
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Condition
Carcinoma, Non-Small Cell Lung
Enrollment
1,006 pts
Location
United States, France, South Korea
Sponsor
Seagen, a wholly owned subsidi
NCT07502495 Phase 2
Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Ach...
Condition
Type 2 Diabetes
Enrollment
60 pts
Location
United States
Sponsor
Biomea Fusion Inc.
NCT06312722 N/A
Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market S...
Condition
Benign Prostatic Hyperplasia
Enrollment
92 pts
Location
United States
Sponsor
Urotronic Inc.
NCT06911424 Phase 3
Recruiting
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Condition
Bacterial Conjunctivitis
Enrollment
400 pts
Location
United States
Sponsor
Baxis Pharmaceuticals, Inc.
NCT07078682 N/A
Recruiting
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Ha...
Condition
Uterine Fibroids
Enrollment
42 pts
Location
United States
Sponsor
Zenchi, Inc.
NCT06754150 N/A
Recruiting
Shoulder Innovations Clinical Data Registry
Condition
Shoulder Arthroplasty
Enrollment
2,500 pts
Location
United States
Sponsor
Shoulder Innovations
NCT07015697 Phase 1
Recruiting
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic S...
Condition
Recurrent or Metastatic Solid Tumors
Enrollment
76 pts
Location
United States, Brazil, France
Sponsor
Daiichi Sankyo
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
NCT05775523 N/A
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatro...
Condition
Growth Hormone Deficiency
Enrollment
500 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
NCT06960213 Phase 3
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Condition
Hereditary Angioedema
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
ADARx Pharmaceuticals, Inc.
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06350097 Phase 3
Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotama...
Condition
Non-small Cell Lung Cancer
Enrollment
582 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
NCT06340568 Phase 3
Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Che...
Condition
Endometrial Cancer
Enrollment
480 pts
Location
United States, Argentina, Australia
Sponsor
BioNTech SE
NCT07380412 N/A
Recruiting
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated W...
Condition
ADHD
Enrollment
90 pts
Location
United States
Sponsor
Outliers, Inc.
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT07661056 Phase 3
Recruiting
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Dise...
Condition
Graves Disease
Enrollment
300 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
Page 1 of 4 — 91 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology